insights_auto
Why is CMXHF up 2,22%?
Dive Deeperchevron_right
CMXHF:OTCMKTS
CSL Ltd
US$123,79
arrow_upward
+2,22%(+2,69) 1D
15 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
US$129,22
High
US$129,22
Low
US$123,79
Mkt. cap
91,33 ຕື້
Avg. vol.
167,00
Volume
564,00
52-wk high
US$148,36
52-wk low
US$63,84
Beta
0,56
Shares outstanding
479,88 ລ້ານ
No. of employees
29 ພັນ
Open
US$129,22
High
US$129,22
Low
US$123,79
Mkt. cap
91,33 ຕື້
Avg. vol.
167,00
Volume
564,00
52-wk high
US$148,36
52-wk low
US$63,84
Beta
0,56
Shares outstanding
479,88 ລ້ານ
No. of employees
29 ພັນ
News stories
From web sources and news partners
TheBull.com.au
·
7 ຊົ່ວໂມງກ່ອນ
CSL Shares Double Off Lows: How Do They Stack Up Against TLX, SIG?
ad-hoc-news.de
·
16 ຊົ່ວໂມງກ່ອນ
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29 ພັນ
Founded1916
Headquartersເມລເບີນ, Victoria, ອອສເຕຣເລຍ
SectorBiotechnology
Websitecsl.com